Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Amgen Inc (AMGN)

Amgen Inc (AMGN)
275.81 x 1 278.45 x 1
Post-market by (Cboe BZX)
277.29 -5.35 (-1.89%) 04/17/25 [NASDAQ]
275.81 x 1 278.45 x 1
Post-market 275.22 -2.07 (-0.75%) 17:01 ET
Quote Overview for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
268.50
Day High
278.68
Open 277.04
Previous Close 282.64 282.64
Volume 4,371,800 4,371,800
Avg Vol 3,652,070 3,652,070
Stochastic %K 37.14% 37.14%
Weighted Alpha -3.84 -3.84
5-Day Change -4.12 (-1.46%) -4.12 (-1.46%)
52-Week Range 253.30 - 346.85 253.30 - 346.85
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 149,085,248
  • Shares Outstanding, K 537,651
  • Annual Sales, $ 33,424 M
  • Annual Income, $ 4,090 M
  • EBIT $ 7,258 M
  • EBITDA $ 12,850 M
  • 60-Month Beta 0.59
  • Price/Sales 4.55
  • Price/Cash Flow 9.31
  • Price/Book 25.85

Options Overview Details

View History
  • Implied Volatility 36.88% ( -3.05%)
  • Historical Volatility 32.25%
  • IV Percentile 83%
  • IV Rank 49.63%
  • IV High 55.92% on 11/20/24
  • IV Low 18.11% on 05/21/24
  • Put/Call Vol Ratio 0.53
  • Today's Volume 8,749
  • Volume Avg (30-Day) 9,611
  • Put/Call OI Ratio 0.88
  • Today's Open Interest 197,918
  • Open Int (30-Day) 185,922

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 30 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 4.15
  • Number of Estimates 12
  • High Estimate 4.45
  • Low Estimate 3.95
  • Prior Year 3.96
  • Growth Rate Est. (year over year) +4.80%

Price Performance

See More
Period Period Low Period High Performance
1-Month
267.40 +3.70%
on 04/09/25
Period Open: 317.17
319.31 -13.16%
on 03/18/25
-39.88 (-12.57%)
since 03/17/25
3-Month
267.40 +3.70%
on 04/09/25
Period Open: 272.11
335.88 -17.44%
on 03/10/25
+5.18 (+1.90%)
since 01/17/25
52-Week
253.30 +9.47%
on 12/19/24
Period Open: 264.07
346.85 -20.05%
on 07/25/24
+13.22 (+5.01%)
since 04/17/24

Most Recent Stories

More News
Here's How You Should Play JNJ Stock After Q1 Earnings Beat

Earlier this week, J&J JNJ began the first-quarter earnings season for the drug and biotech sector with better-than-expected results.J&J’s first-quarter adjusted earnings were $2.77 per share, which...

JNJ : 157.47 (+2.31%)
KVUE : 23.39 (+2.90%)
TEVA : 13.65 (+1.64%)
AMGN : 277.29 (-1.89%)
2 Dividend Stocks Defying the Tariff-Fueled Market Correction to Buy and Hold Forever

Equities are down this year because of Donald Trump's trade policies. The 47th U.S. president decided to impose steep tariffs on imported goods from most countries, although he has since significantly...

AZN : 67.59 (+0.81%)
NVS : 110.86 (+1.17%)
AMGN : 277.29 (-1.89%)
Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks

Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks

SRPT : 53.79 (-0.28%)
BMRN : 59.17 (+0.60%)
ABBV : 172.99 (+0.76%)
MRNA : 24.72 (-1.89%)
AMGN : 277.29 (-1.89%)
JNJ Tops Q1 Earnings, Ups '25 Sales View to Include Intra-Cellular Deal

Johnson & Johnson’s JNJ first-quarter 2025 earnings came in at $2.77 per share, which beat the Zacks Consensus Estimate of $2.57. Earnings rose 2.2% from the year-ago period.Adjusted earnings exclude...

JNJ : 157.47 (+2.31%)
KVUE : 23.39 (+2.90%)
TEVA : 13.65 (+1.64%)
AMGN : 277.29 (-1.89%)
Sandoz Files Antitrust Lawsuit Against Amgen Over Inflammation Drug, Seeks Damages: Retail Sentiment Falters

Sandoz is seeking an injunction to prevent Amgen from using patent rights to block biosimilar competition and allow Sandoz to launch its Erelzi “as soon as possible.”

VOO : 483.90 (+0.14%)
VTI : 258.75 (+0.21%)
AMGN : 277.29 (-1.89%)
Buy, Sell or Hold J&J Stock? Key Tips Ahead of Q1 Earnings

Johnson & Johnson JNJ will begin the earnings season for the drug & biotech sector when it reports its first-quarter 2025 results on April 15. The Zacks Consensus Estimate for first-quarter sales and...

JNJ : 157.47 (+2.31%)
KVUE : 23.39 (+2.90%)
AMGN : 277.29 (-1.89%)
Rule Breaker Investing: Essays From Yesterday, Vol. 7

It's time once again to dust off Motley Fool co-founder David Gardner's old writings and pull some lessons forward into the light of today. In this podcast we discuss buying stocks that you already own,...

NFLX : 973.03 (+1.19%)
NVDA : 101.49 (-2.87%)
FSLR : 127.98 (+2.89%)
BIDU : 82.59 (+0.11%)
BBY : 61.97 (+3.92%)
CHWY : 35.24 (+1.38%)
GILD : 104.54 (-0.32%)
AMGN : 277.29 (-1.89%)
AMZN : 172.61 (-0.99%)
KNSL : 485.70 (+0.42%)
Stocks Spike as Trump Announces 90-Day Tariff Pause

The S&P 500 Index ($SPX ) (SPY ) today is up +5.99%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +3.96%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +7.05%. June E-mini S&P futures (ESM25...

ALK : 45.18 (+1.19%)
GOOGL : 151.16 (-1.42%)
MPC : 127.72 (+2.94%)
AAPL : 196.98 (+1.39%)
JNJ : 157.47 (+2.31%)
AMGN : 277.29 (-1.89%)
PFE : 22.14 (+0.45%)
OXY : 39.71 (+3.28%)
TSLA : 241.37 (-0.07%)
FANG : 137.64 (+5.70%)
AMD : 87.50 (-0.89%)
SPY : 526.41 (+0.14%)
Stocks Supported by Strength in Megacap Technology and Airline Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.49%. June E-mini S&P futures (ESM25...

ALK : 45.18 (+1.19%)
GOOGL : 151.16 (-1.42%)
MPC : 127.72 (+2.94%)
AAPL : 196.98 (+1.39%)
ADI : 176.27 (+0.19%)
JNJ : 157.47 (+2.31%)
AMGN : 277.29 (-1.89%)
PFE : 22.14 (+0.45%)
OXY : 39.71 (+3.28%)
TSLA : 241.37 (-0.07%)
FANG : 137.64 (+5.70%)
AMD : 87.50 (-0.89%)
Big Pharma Stocks Dive Amid Trade War Jitters & Inflation Woes

Stocks of several large-cap pharmaceutical companies plummeted on Friday after China hit back with retaliatory tariffs of 34% on all U.S. imports, escalating fears of a global recession. This move comes...

JNJ : 157.47 (+2.31%)
MRK : 78.00 (+2.01%)
LLY : 839.96 (+14.30%)
ABBV : 172.99 (+0.76%)
AMGN : 277.29 (-1.89%)
PFE : 22.14 (+0.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two...

See More

Key Turning Points

3rd Resistance Point 291.33
2nd Resistance Point 285.00
1st Resistance Point 281.15
Last Price 277.29
1st Support Level 270.97
2nd Support Level 264.64
3rd Support Level 260.79

See More

52-Week High 346.85
Fibonacci 61.8% 311.11
Fibonacci 50% 300.08
Fibonacci 38.2% 289.04
Last Price 277.29
52-Week Low 253.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro